CARRINGTON LABORATORIES INC /TX/ (CARN) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 47 transactions totaling $1.6M, demonstrating a bearish sentiment with -$1.5M in net insider flow. The most recent transaction on Aug 17, 2009 involved a sale of 7,500 shares valued at $600.
No significant insider buying has been recorded for CARN in the recent period.
No significant insider selling has been recorded for CARN in the recent period.
Based on recent SEC filings, insider sentiment for CARN is bearish with an Insider Alignment Score of 3/100 and a net flow of -$1.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CARRINGTON LABORATORIES INC /TX/ (CARN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading CARN stock, having executed 47 transactions in the past 90 days. The most active insider is Marilyn C. Fitzgerald (Executive), who has made 12 transactions totaling $766.0K.
Get notified when executives and directors at CARN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 17, 2009 | J. Schulte Hans | Executive | Sale | 7,500 | $0.08 | $600 | |
| Aug 14, 2009 | J. Schulte Hans | Executive | Sale | 1,500 | $0.08 | $120 | |
| Aug 12, 2009 | J. Schulte Hans | Executive | Sale | 5,000 | $0.08 | $400 | |
| Jul 23, 2009 | J. Schulte Hans | Executive | Sale | 3,900 | $0.09 | $351 | |
| Jul 21, 2009 | J. Schulte Hans | Executive | Sale | 3,500 | $0.07 | $245 | |
| Jul 20, 2009 | J. Schulte Hans | Executive | Sale | 1,000 | $0.07 | $70 | |
| Jul 20, 2009 | J. Schulte Hans | Executive | Sale | 20,000 | $0.07 | $1.4K | |
| Jul 20, 2009 | J. Schulte Hans | Executive | Sale | 20,000 | $0.09 | $1.8K | |
| Jul 20, 2009 | J. Schulte Hans | Executive | Sale | 500 | $0.09 | $45 | |
| Jul 20, 2009 | J. Schulte Hans | Executive | Sale | 20,000 | $0.07 | $1.4K | |
| Jul 15, 2009 | J. Schulte Hans | Executive | Sale | 10,000 | $0.10 | $1.0K | |
| Jul 15, 2009 | J. Schulte Hans | Executive | Sale | 6,351 | $0.09 | $572 | |
| Jul 14, 2009 | J. Schulte Hans | Executive | Sale | 615 | $0.18 | $111 | |
| Jul 13, 2009 | J. Schulte Hans | Executive | Sale | 1,000 | $0.22 | $220 | |
| May 5, 2009 | J. Schulte Hans | Executive | Purchase | 200,000 | $0.05 | $10.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 41 | $1.5M | 97.4% |
Purchase(P) | 5 | $40.7K | 2.6% |
Other(J) | 1 | $0 | 0.0% |
Insider selling pressure at CARRINGTON LABORATORIES INC /TX/ has increased, with 6 insiders executing 47 transactions across all time. Total sales of $1.5M significantly outpace purchases of $40.7K, resulting in a net outflow of $1.5M. This selling activity appears largely discretionary, which may warrant closer attention from investors.